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Abstract Sleep disturbances are common in multiple
sclerosis (MS), but its impact on cognition and functional
connectivity (FC) of the hippocampus and thalamus is
unknown. Therefore, we investigated the relationship
between sleep disturbances, cognitive functioning and
resting-state (RS) FC of the hippocampus and thalamus in
MS. 71 MS patients and 40 healthy controls underwent
neuropsychological testing and filled out self-report ques-
tionnaires (anxiety, depression, fatigue, and subjective
cognitive problems). Sleep disturbances were assed with
the five-item version of the Athens Insomnia Scale. Hip-
pocampal and thalamic volume and RS FC of these regions
were determined. Twenty-three patients were categorized
as sleep disturbed and 48 as normal sleeping. No differ-
ences were found between disturbed and normal sleeping
patients concerning cognition and structural MRI. Sleep
disturbed patients reported more subjective cognitive
problems, and displayed decreased FC between the thala-
mus and middle and superior frontal gyrus, inferior frontal
operculum, anterior cingulate cortex, inferior parietal
gyrus, precuneus, and angular gyrus compared to normal
sleeping patients. We conclude that sleep disturbances in
MS are not (directly) related to objective cognitive
functioning, but rather to subjective cognitive problems. In
addition, sleep disturbances in MS seem to coincide with a
specific pattern of decreased thalamic FC.
Keywords Multiple sclerosis  Cognition  Sleep 
Functional connectivity  fMRI
Introduction
Up to 65 % of multiple sclerosis (MS) patients suffer from
cognitive problems [1], resulting in a reduced quality of
life [2]. Several factors are thought to negatively influence
cognition in MS patients, such as depression [3], fatigue
[4], and sleep disturbances [5]. Approximately 50 % of the
patients with MS suffer from sleep disturbances (e.g.,
insomnia or sleep-disordered breathing) [6].
In healthy controls (HCs), proper sleep is important for
memory consolidation [7] and sleep deprivation has been
related to impaired functioning in various cognitive
domains [8]. The literature on sleep disturbances and
cognition in MS is scarce. One study showed an association
between sleep disturbances and a decline in sustained
attention [9], whereas another study related reduced sleep
efficiency to problems with information processing and
executive function [5].
On functional (f) magnetic resonance imaging (MRI),
the effects of sleep disturbances can be seen as hypo-ac-
tivation in medial and inferior prefrontal areas in subjects
with insomnia compared to HCs during a cognitive task,
which returned to normal values after sleep therapy [10]. In
addition, shallow sleep has been related to reduced hip-
pocampal activation [11], and the thalamus showed
decreased functional connectivity (FC) in sleep deprived
HCs [12].
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In MS, damage to the hippocampus and thalamus (e.g.,
lesions and atrophy) is associated with worse cognition
[13, 14]. In HCs, both regions can be related to sleep and
cognition. In the present study, we investigated sleep dis-
turbances in MS in relation to cognitive functioning and
resting-state (RS) FC of the hippocampus and thalamus.
We hypothesize that sleep problems negatively influence




All patients (n = 71; 47 female; mean disease duration
11.0 years) were diagnosed with clinically definite MS
according to the revisedMcDonald criteria [15].On the day of
scanning, disease severitywasmeasuredusing a questionnaire
based on the expanded disability status scale [16]. Age- and
sex matched HCs (n = 40; 26 female) were included. Sub-
jects included in this study are partly overlapping with a
previously reported fMRI study [17]. Exclusion criteria were
the presence or history of psychiatric or neurological diseases
(for patients: other than MS) and contra-indications for MRI.
All participants gave written informed consent prior to par-
ticipation. The institutional ethical review board approved the
study protocol and it has therefore been performed in accor-
dance with the ethical standards laid down in the 1964 Dec-
laration of Helsinki.
Sleep disturbances
TheAthens Insomnia Scale (AIS) is a self-report questionnaire,
validated in HCs, and was used to measure sleep disturbances
[18]. This questionnaire includes eight items on which a score
ranging fromzero to three points (no to severe problems) canbe
obtained for each item. As the eight-item version of the AIS
includes three items that can reflectMS symptoms independent
from sleep problems (e.g., fatigue during the day), the five-item
version of the AIS was used. This version assesses difficulty
with sleep quality and quantity, and includes the following
items: sleep induction time, awakening during the night, final
awakening earlier than desired, total sleep duration, and overall
quality of sleep.We categorized patients as ‘sleep disturbed’ if
they scored at least three points (which is the median score of
patients) with a prerequisite that at least one item should be
scored C2 (moderate to severe problems). Otherwise, patients
were categorized as ‘normal sleeping’.
Neuropsychological evaluation
All subjects underwent an extensive neuropsychological
test battery, consisting of the following tests:
• The Dutch equivalent of the California Verbal Learning
Test, the Verbale Leer- en Geheugen Taak (VLGT)
[19], to assess verbal learning and memory;
• Letter Digit Substitution Task (LDST; an adaptation of
the symbol digit modalities test) [20], to assess
information processing speed;
• Location Learning Test (LLT) [21], to assess visuospa-
tial memory;
• Digit Span forward and backward, subtests of the
Wechsler Adult Intelligence Scale [22], to assess short
term and working memory, respectively;
• World List Generation, including three categories:
animals, professions, and m-words (1 min per subtest),
to asses verbal fluency [23].
All test scores were converted into Z-scores relative to
HCs. For each subject, all Z-scores were averaged to obtain
an average cognition score. Patients were categorized as
cognitively impaired if they scored at least two standard
deviations below that of HCs on at least two out of five tests.
Otherwise, patients were classified as cognitively preserved.
Symptoms of depression, anxiety, fatigue, and subjec-
tive cognitive problems were assessed using the Hospital
Anxiety and Depression Scale (HADS) [24], the Checklist
of Individual Strength (CIS-20) [25], and the Cognitive
Function Scale (CFS) for subjective cognitive functioning
from the Medical Outcomes study [26].
MRI acquisition
All subjects were scanned on 1.5T (Siemens Sonata,
Erlangen, Germany). Structural MRI consisted of 3DT1-
weighted magnetization prepared rapid acquisition gradi-
ent-echo (MPRAGE) images and turbo spin-echo proton
density (PD)/T2-weighted images. RS fMRI was per-
formed to calculate FC.
Structural MRI analysis
All imaging processing steps were performed in FSL 5.0
(FMRIB’s Software Library, http://www.fmrib.ox.ac.uk/
fsl). Gray matter (GM) and white matter (WM) volumes
were obtained using the MPRAGE images and SienaX
[27]. FIRST [28] was used to measure the volume of the
hippocampus and thalamus. All volumetric measures were
normalized for head size. White matter lesions were
manually marked and outlined on the PD/T2-weighted scan
using a local threshold technique.
Functional MRI analysis
See the online resources for a detailed description of the FC
analysis. In brief, the Automated Anatomical Labelling
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(AAL) atlas [29] was registered to each subject’s fMRI
scan in native space to which subcortical structures were
added. This novel atlas, containing 92 regions, was masked
for GM, and from each atlas region, the average time series
was obtained. FC was calculated between the hippocampus
and thalamus (bilateral) and all other brain areas using
synchronization likelihood (SL) [30] in BrainWave (http://
home.kpn.nl/stam7883/index.html). SL is a measure for
linear and nonlinear correlations and ranges from zero to
one, and has been previously applied in MS [14].
Statistical analysis
All analyses were performed using the Statistical Package
for the Social Sciences (SPSS, Chicago, IL) version 20. All
statistical analyses were performed on group level. Nor-
mality of the data was tested with the Kolmogorov–Smir-
nov test. T2 lesion load was log-transformed, and SL
values were inverted (1/SL) to achieve normality; all the
other non-normally distributed variables were tested with
the Mann–Whitney U test. General linear models were
used to assess group differences. Univariate and multi-
variate regression analyses were used to predict AIS score
and overall cognitive functioning in MS. A p value of 0.05
was considered statistically significant for demographic,
behavioural, and structural MRI data and for the regression
analyses. To be more conservative concerning the multiple
comparisons in the FC analysis, a significance level of 0.01
was used.
Correlations between volumes of the left and right
hippocampus and left and right thalamus were 0.73 and
0.95, respectively. Therefore, volumes of the left and right
hippocampus and left and right thalamus were added up
and treated as single measures to limit the number of
variables in the analyses. In the FC analysis, the left and
right hippocampus and thalamus were analysed separately,
to be more specific.
Results
Demographics, neuropsychological evaluation,
and MRI in MS vs. HCs
See Supplementary Table 1 for detailed information con-
cerning the demographics and cognitive test scores of
patients and HCs. Patients and HCs did not differ signifi-
cantly with respect to age (mean age patients 45.7 years;
mean age HCs 44.0 years; p = 0.338), sex (p = 0.898),
and educational level (median educational level HCs and
patients: 6.00; p = 0.627). Patients show higher levels of
anxiety (p = 0.001), depression (p\ 0.001), fatigue
(p\ 0.001), subjective cognitive problems (p\ 0.001),
and sleep disturbances (p = 0.002) compared to HCs. No
significant relationship was found between AIS score,
fatigue, and subjective cognitive problems in all MS
patients. In HCs, higher AIS score was positively corre-
lated with fatigue (Spearman’s q = 0.57, p\ 0.001).
Patients performed worse on all cognitive tests com-
pared to HCs. In MS, no significant relationship was found
between AIS score and overall objective cognitive func-
tioning or individual neuropsychological test scores.
However, in HCs, higher AIS score was correlated with
worse LDST performance (Spearman’s q = -0.35,
p = 0.026).
MS patients had reduced normalized GM volume
(NGMV; p = 0.001), normalized WM volume (NWMV;
p\ 0.001), normalized hippocampal volume (NHV;
p\ 0.001), and normalized thalamic volume (NTV;
p\ 0.001) compared to HCs. The hippocampus and tha-
lamus showed increased FC in patients compared to HCs
(see Supplementary Table 2).
Sleep disturbances in MS
Twenty-three MS patients (32 %) were classified as having
sleep disturbances (see Table 1). Sleep disturbed patients
reported higher levels of subjective cognitive problems
(p = 0.023) compared to patients with normal sleep.
Cognition
No differences were found between disturbed and normal
sleeping patients with regard to cognitive functioning (see
Table 2). Twelve sleep disturbed patients (52 %) were
categorized as cognitively impaired versus 14 (29 %)
normal sleeping patients (p = 0.060).
Structural MRI
Disturbed and normal sleeping patients did not differ
regarding structural imaging measures (see Table 3).
Functional connectivity
Table 4 displays functional connections that differed between
disturbed and normal sleeping patients. Decreased FC was
observed in sleep disturbed patients compared to normal
sleeping patients between the thalamus and several cortical
regions (see Fig. 1). None of the thalamic connections were
increased. No differences in hippocampal FC were detected.
Predicting AIS score and cognition in MS
To obtain the most important predictors for AIS score in
MS, the relationship between those FC measures that
74 J Neurol (2017) 264:72–80
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differed between disturbed and normal sleeping patients (1/
SL), structural brain measures (NGMV, NWMV, NHV,
NTV, and T2 lesion load), subjective cognitive problems
(confounding variable), and AIS score were assessed using
univariate regression analyses. The predictors that survived
the univariate regression analyses were: NHV (adj.
R2 = 0.06, F = 5.44, b = 0.27, p = 0.023), FC between
the left thalamus and left anterior cingulate cortex (adj.
R2 = 0.05, F = 4.36, b = 0.24, p = 0.040), FC between
the right thalamus and left inferior parietal gyrus (adj.
Table 1 Demographics of
patient groups
Normal sleeping MS patients
(n = 48)
Sleep disturbed MS patients
(n = 23)
p
Age, years 44.55 (8.68) 47.98 (7.14) 0.105
F/M 31/17 16/7 0.678
Educational levela 6.00 (5.00–6.00) 6.00 (5.00–6.00) 0.150
RRMS/SPMS 36/11b 16/7 0.527
Disease duration,
yearsa
10.00 (5.00–14.00) 12.00 (6.00–17.00) 0.360
EDSSa 3.50 (3.50–5.00) 4.00 (3.50–4.63) 0.443
HADS-Aa 5.00 (4.00–7.00) 6.00 (4.00–11.00) 0.075
HADS-Da 4.00 (2.00–6.00) 4.00 (3.00–9.00) 0.144
CIS-20 76.63 (28.85) 84.77 (24.72) 0.256
CFSa 9.00 (7.00–16.00) 15.00 (12.00–20.00) 0.023
A anxiety, CFS Cognitive Function Scale, CIS-20 Checklist of Individual Strength, D depression, EDSS
Expanded Disability Status Scale, F female, HADS Hospital Anxiety and Depression Scale, M male, RRMS
relapsing-remitting multiple sclerosis, SPMS secondary progressive multiple sclerosis
a Indicating median and interquartile range instead of mean and SD
b n = 47
Table 2 Cognitive test scores
for normal sleeping and sleep









Verbal learning and memory
VLGT—total score 55.50 (44.00–62.75) 52.00 (39.00–59.00) 0.304
Visuospatial memory
LLT—total number of displacementsa 16.50 (10.00–30.75) 28.00 (11.00–42.00) 0.169
Information processing speed
LDST (reading, 90 s) 50.50 (45.00–60.75) 47.00 (38.00–55.00) 0.145
Short term and working memory
Digit span forward 9.00 (7.00–10.00)b 8.00 (7.00–10.75)c 0.405
Digit span backward 6.50 (5.00–8.00) 5.00 (4.00–7.00) 0.054
Verbal fluency/memory retrieval
WLG animals 21.50 (17.25–25.00) 21.00 (19.00–27.00) 0.671
WLG professions 16.00 (13.00–20.00) 16.00 (12.00–19.00) 0.666
WLG m-words 9.00 (6.25–12.00) 9.00 (6.00–10.00) 0.336
Overall Z-score -0.68 (-1.17 to -0.27) -1.34 (-1.88 to -0.54) 0.073
Cognitively impaired/cognitively preserved 14/34 12/11 0.060
Displayed data are median and interquartile range
LDST Letter Digit Substitution Task, LLT Location Learning Test, VLGT verbal learning and memory task,
WLG Word List Generation
a The higher the score, the worse the performance
b n = 46
c n = 20
d v2 statistic
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R2 = 0.12, F = 9.21, b = 0.34, p = 0.003), left precuneus
(adj. R2 = 0.07, F = 6.56, b = 0.30, p = 0.013), left
angular gyrus (adj. R2 = 0.05, F = 4.84, b = 0.26,
p = 0.031), right inferior frontal operculum (adj.
R2 = 0.13, F = 9.91, b = 0.35, p = 0.002), and right
superior frontal gyrus (adj. R2 = 0.08, F = 7.46,
b = 0.31, p = 0.008). Multivariate backward regression
analysis revealed that 16.3 % of variance in AIS score
(F = 7.83, p = 0.001) could be explained by FC (1/SL)
between the right thalamus and right inferior frontal
operculum (b = 0.34, p = 0.003) and NHV (b = 0.25,
p = 0.026).
Subsequently, univariate regression analyses were per-
formed to identify the most important predictors for the
overall cognitive functioning in MS, including the fol-
lowing variables: age, sex, educational level, subjective
cognitive problems, NGMV, NWMV, NHV, NTV, and T2
lesions load. The predictors that survived the univariate
regression analyses were: educational level (adj.
R2 = 0.10, F = 8.40, b = 0.33, p = 0.005), NGMV (adj.
R2 = 0.07, F = 6.46, b = 0.29, p = 0.013), NWMV (adj.
R2 = 0.08, F = 7.06, b = 0.31, p = 0.010), NHV (adj.
R2 = 0.10, F = 8.59, b = 0.33, p = 0.005), and NTV
(adj. R2 = 0.12, F = 10.53, b = 0.36, p = 0.002). A
multivariate backward regression analysis demonstrated
that 27.4 % of variance in the overall cognitive functioning
(F = 9.67, p\ 0.001) could be explained by the level of
education (b = 0.42, p\ 0.001), NHV (b = 0.29,
p = 0.016), and NGMV (b = 0.24, p = 0.040). Subse-
quently, AIS score was entered into the model as a second
step after the aforementioned predictors. Entering AIS
score did not result in an increase in explained variance
(b = -0.10, p = 0.362).
Discussion
Sleep disturbances and their effects on cognitive func-
tioning and RS FC of the hippocampus and thalamus in MS
patients were investigated. In our sample, 32 % of the
patients were classified as having sleep disturbances. These
patients had similar cognitive profiles compared to normal
sleeping patients. Interestingly, decreased FC between the
thalamus and the anterior cingulate cortex, precuneus,
superior frontal gyrus, middle frontal gyrus, inferior frontal
operculum, inferior parietal gyrus, and angular gyrus was
Table 3 Structural magnetic
resonance imaging measures for
normal sleeping and sleep
disturbed patients with multiple
sclerosis
Normal sleeping
MS patients (n = 48)
Sleep disturbed
MS patients (n = 23)
p
NGMV, L 0.75 (0.05) 0.74 (0.06) 0.806
NWMV, L 0.65 (0.04) 0.67 (0.05) 0.194
T2 Lesion volume, mL 6.39 (6.00)a 6.20 (5.40) 0.630
NHV, mLb 9.90 (8.29–10.49) 9.62 (9.21–11.23) 0.151
NTV, mLb 18.21 (16.59–19.97) 19.49 (16.69–20.58) 0.253
NGMV normalized gray matter volume, NHV normalized hippocampal volume, NTV normalized thalamic
volume, NWMV normalized white matter volume
a n = 44
b Indicating median and interquartile range instead of mean and SD
Table 4 Functional
connections that differed
between normal sleeping and






MS patients (n = 23)
F p
Thalamus L
Middle frontal gyrus L 0.101 (0.088–0.132) 0.092 (0.073–0.113) 7.203 0.009
Anterior cingulate cortex L 0.102 (0.086–0.127) 0.085 (0.074–0.126) 7.186 0.009
Thalamus R
Superior frontal gyrus R 0.100 (0.083–0.140) 0.083 (0.074–0.101) 8.027 0.006
Inferior frontal operculum R 0.093 (0.083–0.116) 0.081 (0.068–0.097) 7.812 0.007
Precuneus L 0.119 (0.099–0.139) 0.096 (0.083–0.115) 7.714 0.007
Inferior parietal gyrus L 0.101 (0.080–0.127) 0.084 (0.075–0.096) 8.371 0.005
Angular gyrus L 0.080 (0.070–0.096) 0.069 (0.060–0.089) 7.451 0.008
Displayed data are median and interquartile range of untransformed synchronization likelihood
L left, R right
76 J Neurol (2017) 264:72–80
123
Fig. 1 Regions displaying
decreased functional
connectivity with the thalamus
in sleep disturbed compared to
normal sleeping patients. For
illustrative purposes, the atlas
was registered to MNI standard
space (1 mm) and brain regions
were indicated by different
colours. The upper panel
(a) displays all connections of
the left thalamus that showed
decreased functional
connectivity in sleep disturbed
patients compared to normal
sleeping patients. In the lower
panel (b), all connections that
showed decreased functional
connectivity of the right
thalamus in sleep disturbed
patients compared to normal
sleeping patients are visualized
L left, R right
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found in patients with sleep disturbances compared to
normal sleeping MS patients.
Contrary to our hypothesis, we did not observe a dif-
ference in objective cognitive functioning between patients
with and without sleep disturbances that had an equal level
of education and similar structural MRI measures. In our
HCs, only information processing speed was negatively
correlated with AIS score with a minor remark that our
sample had limited variation in AIS score (6/40 HCs were
defined as sleep disturbed).
In line with the literature, we found that sleep disturbed
patients reported increased subjective cognitive problems.
This was previously found in a large sample of 5171 HCs,
in which the relationship between sleep disturbances and
subjective cognitive functioning was stronger than that
with objective cognitive functioning [31].
Although the literature is scarce, it was previously
shown that subjective sleep problems in MS patients (with
unknown disease duration) could be related to a decline in
sustained attention during sequential sessions of a working
memory task [9], whereas another study related poor sleep
efficiency (measured using polysomnography and a multi-
sleep latency test) to worse global cognitive performance
(especially executive function and information processing)
[5]. In the latter study, 32 patients (mean disease duration
7.5 years) were included and all treated with natalizumab.
The difference in patient characteristics might explain the
opposite findings since patients in the current study had an
average disease duration of 10 years and varied concerning
medication. Differences in the sleep measurements (i.e.,
questionnaires versus polysomnography) and samples
might explain the discrepancy in results. Unfortunately, the
previous studies did not include MRI to investigate the
underlying brain mechanisms of sleep problems.
With regard to FC, patients with MS displayed exclu-
sively increased FC in 22 hippocampal and thalamic
connections relative to HCs, of which seven were related to
the overall cognitive functioning (data not shown). With
regard to sleep, patients with sleep disturbances showed
decreased FC of thalamic connections compared to normal
sleeping patients. In addition, the most important predictors
for sleep disturbances in MS were: reduced FC between the
right thalamus and right frontal operculum and larger
hippocampal volume. The latter observation might be
explained by the use of a self-report questionnaire to assess
sleep disturbances. Although the link between self-report
questionnaires and hippocampal volume has not been
investigated to our knowledge, a previous study in MS
found a similar relationship between larger hippocampal
volume and higher levels of self-reported cognitive prob-
lems [32].
To our knowledge, this is the first study that investigated
sleep disturbances in MS and its association with FC
changes. Studies in HCs showed a link between decreased
FC and sleep disturbances. For example, after sleep
deprivation, decreased FC can be observed in the default
mode network [33] and the thalamus [12]. Decreased FC
between the thalamus and other regions, such as the
superior frontal gyrus, gyrus rectus, precentral gyrus,
postcentral gyrus, middle temporal gyrus, and anterior
occipital lobe, was also found to be related to daytime
sleepiness in an epidemiological study [34]. In the current
study, we observed a decrease in FC of the thalamus in
sleep disturbed patients, especially in connections between
the thalamus and frontal areas (superior and middle frontal
gyrus and inferior frontal operculum). This observation is
in line with findings in HCs with sleep disturbances.
Thalamic connections that are affected when having
sleep disturbances are different from the thalamic con-
nections that are hampered when having cognitive distur-
bances in MS. In addition, a decrease in connectivity is
seen for the sleep disturbed patients, while in relation to
cognitive impairment, increased connectivity is mostly
reported [14]. Patterns of decreased thalamocortical FC
have also been observed in sleep deprived HCs [12].
Although it is not completely elucidated what the under-
lying mechanism is, in sleep deprived HCs, it was previ-
ously suggested to be a result of a decrease in brain
metabolism (especially in frontal regions and the thalamus)
as measured with positron emission tomography [35],
possibly resulting in less synchronized firing of neurons.
Our study suggests that a lack of sleep is related to highly
specific changes in thalamic-cortico connectivity, which is
not directly related to cognitive performance in MS
patients.
One possible explanation for the absent relationship
between sleep disturbances and cognitive performance
might be that patients with severe sleep disturbances were
not included in this sample, as subjects were not recruited
based on their sleeping behavior. It can be hypothesized
that severely sleep disturbed MS patients will be more
similar to sleep deprived HCs, and perhaps do show
impaired cognition. In our sample, the percentage of
patients with sleep disturbances (32 %) was lower than
reported previously (*50 %) [6]. The different numbers
might be explained by the use of different self-report
questionnaires. In the present study, we used the AIS which
is a self-report questionnaire that has been validated in HCs
[18]. Although it has not been validated in MS, it has been
administered in other diseases, such as Alzheimer’s disease
[36], which warrants its use in MS. Furthermore, the
internal validity of the questionnaire in the present sample
(Cronbach’s alpha) for MS patients and HCs was 0.70 and
0.74, respectively. The included items of the AIS assess
problems with quality and quantity of sleep, and are not
specific for the type of sleep problems that can be found
78 J Neurol (2017) 264:72–80
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due to MS (e.g., spasticity, sleep apnea, or pain). As no
definition has been previously published for the five items
version of the AIS, we defined sleep disturbances as
scoring at least three points (i.e., median score of patients)
with the prerequisite of scoring moderate to severe on at
least one item, thereby aiming to be a bit more conservative
than using, for instance, a median split approach. A pre-
vious study has shown that objective measures of sleep
disturbances, such as obstructive sleep apnea, can be
related to cognitive dysfunction in MS [37]. Hence,
objective measures to quantify sleep disturbances, such as
polysomnography, might give a more precise reflection
than a self-report questionnaire of the sleep deficits being
present. However, we do not expect that if we would have
included objective measures of sleep disturbances, patients
would have been categorized entirely different.
While FC changes in sleep disturbed MS patients follow
a similar pattern compared to changes in connectivity in
sleep deprived HCs, it might well be that the effect on
cognitive performance is absent due to brain damage
caused by MS. Our results suggest that educational level,
hippocampal volume, and GM volume can predict overall
cognitive functioning. Adding AIS score into the model did
not improve the prediction of overall cognitive functioning.
Hence, we hypothesize that the severity of structural brain
damage in MS patients might be of more influence on
cognition than the presence of sleep disturbances. That is,
cortical and subcortical GM pathology, but also WM
abnormalities, has been linked to impaired cognition in
MS. The (widespread) structural brain abnormalities might
limit the additional effect of sleep disturbances on cogni-
tion. It would be interesting to investigate an early cohort
of patients with relatively mild brain pathology to see if
sleep disturbances in that stage of the disease do (still)
explain part of the cognitive deficits.
In summary, sleep disturbances, as measured with the
AIS, in MS do not directly relate to objective cognitive
functioning, but rather to subjective cognitive problems.
The distinct FC pattern of the thalamus of sleep disturbed
MS patients should be investigated in more depth to
understand the complex interplay between sleep, cognition,
and brain pathology in MS.
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